Répertoire de l'Université Alfonso X el Sabio

Fluorescence diagnosis and photodynamic therapy for Bowen¿s disease treatment

Afficher la notice abrégée

APA

Truchuelo, M.T. & Pérez, B. & Fernández Guarino, Montserrat & Moreno, C. & Jaén Olasolo, P. (2013 ) .Fluorescence diagnosis and photodynamic therapy for Bowen¿s disease treatment.

ISO 690

Truchuelo, M.T. & Pérez, B. & Fernández Guarino, Montserrat & Moreno, C. & Jaén Olasolo, P.. 2013 .Fluorescence diagnosis and photodynamic therapy for Bowen¿s disease treatment.

https://hdl.handle.net/20.500.12080/39636
dc.contributor.author Truchuelo, M.T.
dc.contributor.author Pérez, B.
dc.contributor.author Fernández Guarino, Montserrat
dc.contributor.author Moreno, C.
dc.contributor.author Jaén Olasolo, P.
dc.date.accessioned 2024-02-09T10:28:25Z
dc.date.available 2024-02-09T10:28:25Z
dc.date.created 2013
dc.date.issued 2013
dc.identifier.uri https://hdl.handle.net/20.500.12080/39636
dc.description.abstract Introduction It has already been demonstrated the high efficacy of photodynamic therapy (PDT) for Bowen¿s disease (BD) treatment. Fluorescence diagnosis consists on registration of the fluorescence emitted by tissue after application of a photosensitizer, indicating presence of tumoral cells. It has been described as a useful tool for actinic keratosis. Different results have been published about fluorescence diagnosis for basal cell carcinomas. Very few reports about the role of fluorescence diagnosis for this entity exist and this is the first one which correlates the fluorescence image after PDT with the histopathological response. Objectives To assess the role of fluorescence diagnosis during BD follow-up. Methods We carried out an observational, retrospective and descriptive study. A total of 29 BD biopsy proven lesions were included. All the lesions had been treated with the standard protocol (Topical methyl- aminolaevulinic acid under occlusion for 3 hours and followed by illumination with red-light (630 nm, 38J ¿ cm2 , 7.5 minutes. Two sessions one week apart). Clinical and fluorescence photographs were taken before treatment and one month after the 2nd one. At that moment a post-treatment biopsy was performed. Clinical response was classified as partial, complete or no response. Fluorescence response was classified as negative, intermediate or intense. The follow-up period and the adverse events observed including pain were also collected. Results We found statistical association between fluorescence and the clinical and histopathological evaluations performed after treatment. Fluorescence diagnosis obtained a 100% sensitivity (higher than clinical evaluation alone) and a specificity of 85.7% (CI: 70.8-100). Conclusions Fluorescence diagnosis seems a valid diagnostic tool, useful during the follow up of Bowen disease lesions with the advantage of avoiding unnecessary post-treatment biopsies. es_ES
dc.format application/pdf es_ES
dc.language eng es_ES
dc.rights CC-BY es_ES
dc.rights.uri http://creativecommons.org/licenses/by/4.0/deed.es es_ES
dc.title Fluorescence diagnosis and photodynamic therapy for Bowen¿s disease treatment es_ES
dc.type info:eu-repo/semantics/article es_ES
dc.rights.accessrights info:eu-repo/semantics/restrictedAccess es_ES
dc.identifier.location N/A es_ES


Fichier(s) constituant ce document

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée

CC-BY Excepté là où spécifié autrement, la license de ce document est décrite en tant que CC-BY

Chercher dans le dépôt


Parcourir

Mon compte

Social Media